Evaluate Research Issues a new Update Note on United Bancorp: 3rd Dividend Hike in 2021, 4.8% Total Dividend Yield
As a reminder, UBCP has declared 5 Special Dividends during the past 5 years, which highlights the board’s keen focus on rewarding shareholders with a high yield. These dividend hikes continue a strong 39 year tradition of UBCP increasing dividends for shareholders. The Special Dividend suggests management remains quite confident in UBCP’s financial strength and earnings outlook.
Presently, UBCP’s stock is trading at 1.2x trailing tangible price/book, and a 9.6x P/E, 4.2% yield, and 1.0 price/book based on our 2022 estimates. Our $20.00 price target implies a forward P/E multiple of 13.4x on our forward 2022 estimate, which is a huge discount to the overall market. Our target price also suggests a 3.0% dividend yield and a 1.4x price/book on our 2022 dividend and year-end book value estimates.
UBCP is in a strong position to benefit from increasing loan demand as the economy continues to recover. In addition to ample liquidity, UBCP remains well capitalized with an 18.1% total risk-based capital ratio as of March 31, 2021, the latest disclosed information in the company’s most recent 10-Q filing. Of this, Tier 1 capital [to risk-weighted assets] was also at a healthy 13.3%, suggesting solid levels of both total capital as well as Tier 1 capital. Total stockholders’ equity in relation to total assets was 9.5% on June 30, 2021, up from 9.1% at March-end, and up slightly from the 9.4% level reported at Q2-end last year.
This communication is issued by EVALUATE RESEARCH LTD. and is not a solicitation for investment. It is not guaranteed as to accuracy, nor is it a complete statement, of the companies/securities referred to. This press release/all reports are based on information available to the public; no representation is made with regard to its accuracy or completeness. Opinions are subject to change without notice. To the extent permitted by law, Evaluate does not accept any liability arising from the use of this communication. See complete important risk information & disclosures on our website and in all reports.
Sandy Mehta
Evaluate Research
+1 617-848-8279
sandy@evaluateresearch.com
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.